Abstract

The etiology of diet-related disorders is closely associated with dietary factors. A special role is attributed to intake of fat and fatty acid profile, both quantitative and qualitative. For prevention and treatment of the abovementioned diseases a proper supply of unsaturated fatty acids plays a significant role, because of their particular importance to health. γ-Linolenic acid (GLA), with three double bonds in the carbon chain, also known as all-cis 6,9,12-octadecatrienoic acid, belongs to the n-6 family of fatty acids. It plays biologically important functions in the human body, such as being a substrate for eicosanoids synthesis, involvement in the transport and oxidation of cholesterol, and being one of the components of lipid membrane. Its inadequate dietary intake or impaired formation is the cause of many inflammatory and degenerative diseases. A rich source of this fatty acid is vegetable oils, until recently used mainly in folk medicine. Nowadays, studies conducted both in animal models and in humans suggest its health-promoting properties in the prevention and treatment of atopic dermatitis, cardiovascular diseases, diabetes, cancers and rheumatoid arthritis.

References

• 1. Alabdulkarim B., Bakeet Z.A., Arzoo S.: Role of some functionallipids in preventing diseases and promoting health. J. King SaudUniversity – Science, 2012; 24: 319-329
  Google Scholar
• 2. Aragona P., Bucolo C., Spinella R., Giuffrida S., Ferreri G.: Systemicomega-6 essential fatty acids treatment and PGE1 tear contentin Sjögren’s syndrome patients. Invest. Ophthalmol. Vis. Sci., 2005;46: 4474-4479
  Google Scholar
• 3. Barabino S., Rolando M., Camicione P., Ravera G., Zanardi S., GiuffridaS., Calabria G.: Systemic linoleic and g-linolenic acid therapyin dry-eye syndrome with an inflammatory component. Cornea,2003; 22: 97-101
  Google Scholar
• 4. Barre E.: Potential of evening primrose, borage, black currantand fungal oils in human health. Ann. Nutr. Metab., 2001; 45: 47-57
  Google Scholar
• 5. Bayles B., Usatine R.: Evening primrose oil. Am. Fam. Physician,2009; 80: 1405-1408
  Google Scholar
• 6. Białek A., Tokarz A.: Sprzężone dieny kwasu linolowego jako potencjalnyczynnik prewencyjny w profilaktyce nowotworów piersi.Postępy Hig. Med. Dośw., 2013; 67: 6-14
  Google Scholar
• 7. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., RawlingsR.R.: Changes in consumption of omega-3 and omega-6 fattyacids in the United States during the 20th century. Am. J. Clin. Nutr.,2011; 93: 950-962
  Google Scholar
• 8. Brenner R.R.: Hormonal modulation of Δ6 and Δ5 desaturases:case of diabetes. Prostaglandins Leukot. Essent. Fatty Acids, 2003;68: 151-162
  Google Scholar
• 9. Burdan F., Chałas A., Szumiło J.: Cyklooksygenaza i prostanoidy– znaczenie biologiczne. Postępy Hig. Med. Dośw., 2006; 60: 129-141
  Google Scholar
• 10. Callaway J., Schwab U., Harvima I., Halonen P., Mykkänen O.,Hyvönen P., Järvinen T.: Efficacy of dietary hempseed oil in patientswith atopic dermatitis. J. Dermatolog. Treat., 2005; 16: 87-94
  Google Scholar
• 11. Chilton F.H., Rudel L.L., Parks J.S., Arm J.P., Seeds M.C.: Mechanismsby which botanical lipids affect inflammatory disorders. Am.J. Clin. Nutr., 2008; 87: 498S-503S
  Google Scholar
• 12. Christie W.W.: The analysis of evening primrose oil. Ind. Crop.Prod., 1999; 10: 73-83
  Google Scholar
• 13. Das U.N.: Essential fatty acids and their metabolites in the contextof hypertension. Hypertens. Res., 2010; 33: 782-785
  Google Scholar
• 14. Das U.N.: Do polyunsaturated fatty acids behave like and endogenous“polypill”? Med. Hypotheses, 2008; 70: 430-434
  Google Scholar
• 15. Decyzja KE z dnia 27 czerwca 2008 zezwalająca na wprowadzaniedo obrotu rafinowanego oleju ze żmijowca jako nowego składnikażywności zgodnie z rozporządzeniem (WE) nr 258/97 ParlamentuEuropejskiego i Rady
  Google Scholar
• 16. Diraman H., Koru E., Dibeklioglu H.: Fatty acids profile of Spirulinaplatensis used as a food supplement. Isr. J. Aquacult. Bamid.,2009; 61: 134-142
  Google Scholar
• 17. Ebbesson S.O., Lopez-Alvarenga J.C., Okin P.M., Devereux R.B.,Tejero M.E., Harris W.S., Ebbesson L.O., MacCluer J.W., Wenger C.,Laston S., Fabsitz R.R., Kennish J., Howard W.J., Howard B.V., UmansJ., Comuzzie A.G.: Heart rate is associated with markers of fattyacid desaturation: the GOCADAN study. Int. J. Circumpolar Health,2012; 71: 17343
  Google Scholar
• 18. Engler M.M., Engler M.B.: The effects of dietary evening primrose,black currant, borage and fungal oils on plasma, hepatic andvascular tissue fatty acid composition in the spontaneously hypertensiverat. Nutr. Res., 1998; 18: 1533-1544
  Google Scholar
• 19. Fan Y.Y., Chapkin R.S.: Importance of dietary γ-linolenic acid inhuman health and nutrition. J. Nutr., 1998; 128: 1411-1414
  Google Scholar
• 20. Foster R.H., Hardy G., Alany R.G.: Borage oil in the treatment ofatopic dermatitis. Nutrition, 2010; 26: 708-718
  Google Scholar
• 21. Główny Urząd Statystyczny. http://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/struktura-ludnosci-do-2013-r-,16,1.html
  Google Scholar
• 22. Guillou H., Zadravec D., Martin P.G., Jacobsson A.: The key rolesof elongases and desaturases in mammalian fatty acids metabolism:insights from transgenic mice. Prog. Lipid Res., 2010; 49: 186-199
  Google Scholar
• 23. He C., Qu X., Wan J., Rong R., Huang L., Cai C., Zhou K., Gu Y.,Qian S.Y., Kang J.X.: Inhibiting delta-6 desaturase activity suppressestumor growth in mice. PLoS One, 2012; 7: e47567
  Google Scholar
• 24. Hofacer R., Jandacek R., Rider T., Tso P., Magrisso I.J., BenoitS.C., McNamara R.K.: Omega-3 fatty acid deficiency selectively up–regulates delta6-desaturase expression and activity indices in ratliver: prevention by normalization of omega-3 fatty acids status.Nutr. Res., 2011; 31: 715-722
  Google Scholar
• 25. Hornych A., Oravec S., Girault F., Forette B., Horrobin D.F.: Theeffect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandins synthesis in older subjects. Bratisl. Lek. Listy,2002, 103: 101-107
  Google Scholar
• 26. Horrobin D.: Fatty acid metabolism in health and disease: therole of Δ-6-desaturase. Am. J. Clin. Nutr., 1993; 57: 732S-737S
  Google Scholar
• 27. Horrobin D.F.: Essential fatty acids in the management of impairednerve function in diabetes. Diabetes, 1997; 46 (Suppl. 2): S90-S93
  Google Scholar
• 28. Hounsom L., Horrobin D.F., Tritschler H., Corder R., TomlinsonD.R.: A lipoic acid-gamma linolenic acid conjugate is effective againstmultiple indices of experimental diabetic neuropathy. Diabetologia,1998; 41: 839-843
  Google Scholar
• 29. Jakubowski A., Żołnierz-Piotrowska M., Grześkiewicz S.: Poszukiwaniasurowców mogących być źródłem olejów zawierającychkwas g-linolenowy (GLA; C18:3Δ 6,9,12). Tłuszcze Jadalne XXVIII,1990; 3: 15-19
  Google Scholar
• 30. Jamal G.A., Carmichael H.: The effect of g-linolenic acid on humandiabetic peripheral neuropathy: a double-blind placebo-controlledtrial. Diabet. Med., 1990: 7: 319-323
  Google Scholar
• 31. Javadi M., Everts H., Hovenier R., Kocsis S., Lankhorst A.E., LemmensA.G., Schonewille J.T., Terpstra A.H., Beynen A.C.: The effectof six different C18 fatty acids on body fat and energy metabolismin mice. Br. J. Nutr., 2004; 92: 391-399
  Google Scholar
• 32. Jelińska M.: Kwasy tłuszczowe – czynniki modyfikujące procesynowotworowe. Biul. Wydz. Farm. AMW (obecnie WUM), 2005; 1
  Google Scholar
• 33. Jelińska M., Gielecińska I., Mojska H., Tokarz A.: Walidacja oznaczaniawybranych eikozanoidów metodą LC-MS/MS. Bromat. Chem.Toksykol., 2012; 3: 943-948
  Google Scholar
• 34. Jelińska M., Tokarz A.: Nowe oblicza starych znajomych – przeciwzapalnemetabolity n-3 WNKT. Cz. II. Bromat. Chem. Toksykol.,2013; 3: 258-266
  Google Scholar
• 35. Jiang W.G., Hiscox S., Hallett M.B., Horrobin D.F., Mansel R.E.,Puntis M.C.: Regulation of the expression of E-cadherin on humancancer cells by g-linolenic acid (GLA). Cancer Res., 1995; 55: 5043-5048
  Google Scholar
• 36. Karmali R.A.: Dietary ώ-3 and ώ-6 fatty acids in cancer. W: Dietaryώ-3 and ώ-6 fatty acids. Biological Effects and Nutritional Essentiality,vol. 171, red.: C. Galli, A.P, Simopoulos. Plenum Press incooperation with NATO Scientific Affairs Division, 1989; 351-359
  Google Scholar
• 37. Keen H., Payan J., Allawi J., Walker J., Jamal G.A., Weir A.I., HendersonL.M., Bissessar E.A., Watkins P.J., Sampson M., Gale E.A., ScarpelloJ., Boddie H.G., Hardy K.J., Thomas P.K., Misra P., Halonen J.P.:Treatment of diabetic neuropathy with g-linolenic acid. DiabetesCare, 1993; 16: 8-15
  Google Scholar
• 38. Khan S.A., Vanden Heuvel J.P: Role of nuclear receptors in theregulation of gene expression by dietary fatty acids (review). J. Nutr.Biochem., 2003; 14: 554-567
  Google Scholar
• 39. Kim D.H., Yoo T.H., Lee S.H., Kang H.Y., Nam B.Y., Kwak S.J., KimJ.K., Park J.T., Han S.H., Kang S.W.: Gamma linoleic acids exerts anti-inflammatoryand anti-fibrotic effects in diabetic neuropathy.Yonsey Med. J., 2012; 53: 1165-1175
  Google Scholar
• 40. Kong X., Ge H., Chen L., Liu Z., Yin Z., Li P., Li M.: Gamma-linolenicacid modulates the response of multidrug-resistant K562 leukemiccells to anticancer drugs. Toxicol. In Vitro, 2009; 23: 634-639
  Google Scholar
• 41. Król B., Kowalski R.: Zawartość kwasów tłuszczowych oleju żmijowca(Echium ssp. L.) – potencjalnego surowca w profilaktyce, terapiii żywieniu. Żyw. Człow. Metab., 2004; 31 (Suppl. 2): 166-170
  Google Scholar
• 42. Kulshreshtha A., Zacharia A.J., Jarouliya U., Bhadauriya P., PrasadG.B., Bisen P.S.: Spirulina in health care management. Curr. Pharm.Biotechnol., 2008; 9: 400-405
  Google Scholar
• 43. Laidlaw M., Holub B.J.: Effects of supplementation with fishoil-dervived n-3 fatty acids and g-linolenic acid on circulating plasmalipids and fatty acid profiles in women. Am. J. Clin. Nutr., 2003;77: 37-42
  Google Scholar
• 44. Lamer-Zarawska E.: Olej wiesiołkowy w profilaktyce, terapiii kosmetyce. W: Zbiór prac II sympozjum n.t. Olej z nasion wiesiołkaw profilaktyce i terapii. MakoLab, Łódź 1995, 35-51
  Google Scholar
• 45. Lands W.E., Morris A., Libelt B.: Quantitative effects of dietarypolyunsaturated fats on the composition of fatty acids in rat tissues.Lipids, 1990; 25: 505-516
  Google Scholar
• 46. Larque E., Garcia-Ruiz P.A., Perez-Llamas F., Zamora S., Gil A.:Dietary trans fatty acids alter the composition of microsomes andmitochondria and the activities of microsome Δ6-fatty acid desaturaseand glucose-6-phosphatase in liver of pregnant rats. J. Nutr.,2003; 133: 2526-2531
  Google Scholar
• 47. Macri A., Giuffrida S., Amico V., Iester M., Traverso C.E.: Effect oflinoleic acid and g-linolenic acid on tear production, tear clearanceand on the ocular surface after photorefractive keratectomy. GraefesArch. Clin. Exp. Ophthalmol., 2003; 241: 561-566
  Google Scholar
• 48. Mayes P.A.: Utlenianie kwasów tłuszczowych: ketogeneza. W:Biochemia Harpera, wyd. 6, red.: R.K. Murray, D.K. Granner, V.W.Rodwell. PZWL, Warszawa 2014: 260-265
  Google Scholar
• 49. Muggli R.: Systemic evening primrose oil improves the biophysicalskin parameters of healthy adults. Int. J. Cosmet. Sci., 2005;27: 243-249
  Google Scholar
• 50. Nakamura M.T., Nara T.Y.: Structure, function and dietary regulationof Δ6, Δ5 and Δ9 desaturases. Annu. Rev. Nutr., 2004; 24:345-376
  Google Scholar
• 51. Nicolaou A.: Eicosanoids in skin inflammation. ProstaglandinsLeukot. Essent. Fatty Acids, 2013; 88: 131-138
  Google Scholar
• 52. Nowak J.Z.: Przeciwzapalne „powygaszeniowe” pochodne wielonienasyconychkwasów tłuszczowych omega 3 i omega 6. PostępyHig. Med. Dośw., 2010; 64: 115-132
  Google Scholar
• 53. Nyalala J.O., Wang J., Dang A., Faas F.H., Smith W.G.: Hypertriglyceridemiaand hypercholesterolemia: effect of drug treatmenton fatty acid composition of plasma lipids and membranes. ProstaglandinsLeukot. Essent. Fatty Acids, 2008; 78: 271-280
  Google Scholar
• 54. Pereira S.L., Leonard A.E., Mukerji P.: Recent advances in thestudy of fatty acid desaturases from animals and lower eukarotes.Prostaglandins Leukot. Essent. Fatty Acids, 2003; 68: 97-106
  Google Scholar
• 55. Pham H., Vang K., Ziboh V.A.: Dietary γ-linolenate attenuatestumor growth in a rodent model of prostatic adenocarcinoma viasuppression of elevated generation of PGE2 and 5S-HETE. ProstaglandinsLeukot. Essent. Fatty Acids, 2006; 74: 271-282
  Google Scholar
• 56. Pinna A., Piccinini P., Carta F.: Effect of oral linoleic andγ-linolenic acid on meibomian gland dysfunction. Cornea, 2007;26: 260-264
  Google Scholar
• 57. Raatz S.K., Young L.R., Picklo M.J. Sr, Sauter E.R., Qin W., KurzerM.S.: Total dietary fat and fatty acid content modifies plasma phospholipidfatty acids desaturase activity indices, and urinary prostaglandinE in women. Nutr. Res., 2012; 32: 1-7
  Google Scholar
• 58. Rutkowska J., Żbikowska A.: Jakość wybranych olejów roślinnychdostępnych na polskim rynku. Rocz. Panstw. Zakl. Hig., 2007;58: 515-524
  Google Scholar
• 59. Schirmer M.A., Phinney S.D.: γ-linolenate reduces weight regainin formerly obese humans. J. Nutr., 2007; 137: 1430-1435
  Google Scholar
• 60. Schwab U.S., Callaway J.C., Erkkilä AT., Gynther J., Uusitupa M.I.,Järvinen T.: Effects of hempseed and flaxseed oils on the profile ofserum lipids, serum total and lipoprotein lipid concentrations andhaemostatic factors. Eur. J. Nutr., 2006; 45: 470-477
  Google Scholar
• 61. Sharma A.K., Raj H., Pandita A., Tandon V.R., Mahajan A.: Gammalinolenic acid in dry eye. JK Science, 2006; 8: 24-27
  Google Scholar
• 62. Skoczyńska A., Smolik R., Budziszewska D.: Metale ciężkie i śladowewe krwi u pacjentów leczonych olejem wiesiołkowym z powoduhipercholesterolemii. W: Zbiór prac II sympozjum n.t. Olej z nasionwiesiołka w profilaktyce i terapii. MakoLab, Łódź 1995, 131-135
  Google Scholar
• 63. Spector A.A., Yorek M.A.: Membrane lipid composition and cellularfunction. J. Lipid Res., 1985; 26: 1015-1035
  Google Scholar
• 64. Stawarska A., Białek A., Stanimirova I., Stawarski T., Tokarz A.:The effect of conjugated linoleic acids (CLA) supplementation onthe activity of enzymes participating in the formation of arachidonicacid in liver microsomes of rats – probable mechanism of CLAanticancer activity. Nutr. Cancer, 2015; 67: 145-155
  Google Scholar
• 65. Stawarska A., Tokarz A., Seweryn T.: Wpływ wybranych czynnikówdietetycznych na aktywność Δ6-desaturazy w mikrosomachwątrobowych szczurów. Bromat. Chem. Toksykol., 2012, 3: 427-432
  Google Scholar
• 66. Stołyhwo A.: Wybrane, analityczne kryteria oceny jakości oleju„dziewiczego” z nasion wiesiołka Oe. paradoxa. Hudziok. W: Zbiórprac II sympozjum n.t.: Olej z nasion wiesiołka w profilaktyce i terapii.MakoLab, Łódź 1995, 13-21
  Google Scholar
• 67. Sulicka J., Fornal M., Gryglewska B., Wizner B., Grodzicki T.:Wybrane czynniki ryzyka chorób sercowo-naczyniowych u pacjentówpodstawowej opieki zdrowotnej. Nadciśnienie Tętnicze, 2006;10: 370-376
  Google Scholar
• 68. Surette M.E., Edens M., Chilton F.H., Tramposch KM.: Dietaryechium oil increases plasma and neutrophil long-chain (n-3) fattyacids and lowers serum triacyloglycerols in hypertriglyceridemichumans. J. Nutr., 2004; 134: 1406-1411
  Google Scholar
• 69. Takada R., Saitoh M., Mori T.: Dietary γ-linolenic acid-enrichedoil reduces body fat content and induces liver enzyme activitiesrelating to fatty acid β-oxidation in rats. J. Nutr., 1994; 124: 469-474
  Google Scholar
• 70. Takwale A., Tan E., Agarwal S., Barclay G., Ahmed I., HotchkissK., Thompson J.R., Chapman T., Berth-Jones J.: Efficacy and tolerabilityof borage oil in adults and children with atopic eczema: randomized,double blind, placebo controlled, parallel group trial. Br.Med. J., 2003; 327: 1385
  Google Scholar
• 71. Thijssen M.A., Malpuech-Brugere C., Gregoire S., Chardigny J.M.,Sebedio J.L., Mensink R.P.: Effect of specific CLA isomers on plasmafatty acid profile and expression of desaturases in humans. Lipids,2005; 40: 137-145
  Google Scholar
• 72. Tokarz A., Stawarska A., Kopeć G.: Wpływ tłuszczów diety i dimetylobenzantracenuna aktywność Δ-6 desaturazy w mikrosomachwątrobowych szczurów. Bromat. Chem. Toksyk., 2002; 35: 209-214
  Google Scholar
• 73. Tso P., Caldwell J., Lee D., Boivin G.P., DeMichele S.J.: Comparisonof growth, serum biochemistries and n-6 fatty acid metabolism inrats fed diets supplemented with high-gamma-linolenic acid saffloweroil or borage oil for 90 days. Food Chem. Toxicol., 2012; 50:1911-1919
  Google Scholar
• 74. Van Gool C.J., Thijs C., Henquet C.J., van Houwelingen A.C.,Dagnelie P.C., Schrander J., Menheere P.P., van den Brandt P.A.:γ-Linolenic acid supplementation for prophylaxis of atopic dermatitis– a randomized controlled trail in infants at high familial risk.Am. J. Clin. Nutr., 2003; 77: 943-951
  Google Scholar
• 75. Vessby B., Ahren B., Warensjö E., Lindgarde F.: Plasma lipid fattyacid composition, desaturase activities and insulin sensitivity inAmerindian women. Nutr. Metab. Cardiovasc. Dis., 2012; 22: 176-181
  Google Scholar
• 76. Wadhwani N.S., Manglekar R.R., Dangat K.D., Kulkarni A.V., JoshiS.R.: Effect of maternal micronutrients (folic acid, vitamin B12)and omega 3 fatty acids on liver fatty acid desaturases and transportproteins in Wistar rats. Prostaglandins Leukot. Essent. FattyAcids, 2012; 86: 21-27
  Google Scholar
• 77. Wertz P.W.: Lipids and barrier function of the skin. Acta Derm.Venereol. Suppl., 2000; 208: 7-11
  Google Scholar
• 78. World Cancer Resarch Fund/American Institute for Cancer Research.Food, Nutrition, Physical Activity, and the Prevention ofCancer: a Global Perspective. Washington, DC: AICR, 2007
  Google Scholar
• 79. World Health Organization. Nutrition disorders. http://www.who.int/topics/nutrition_disorders/en/(21.03.2015)
  Google Scholar
• 80. Zatonski W., Campos H., Willett W.: Rapid declines in coronaryheart disease mortality in Eastern Europe are associated withincreased consumption of oils rich in alpha-linolenic acid. Eur. J.Epidemiol., 2008; 23: 3-10
  Google Scholar
• 81. Zietemann V., Kröger J., Enzenbach C., Jansen E., Fritsche A., WeikertC., Boeing H., Schulze M.B.: Genetic variation of FADS1 FADS2gene cluster and n-6 PUFA composition in erythrocyte membranesin The European Prospective Investigation into Cancer and Nutrition-Postdamstudy. Br. J. Nutr., 2010, 104: 1748-1759
  Google Scholar

Full text